Under resourced. Over worked. - Director bei Genentech: Mitarbeiterbewertung

3.0
8. Mai 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Patient centric Amazing medicines Some good people

Kontras

Political. Overwork people because won’t fund sufficient roles. Bad mid level managers Flat. No way to move up. Does not live its culture. All talk.

Mehr Bewertungen zu Genentech entdecken

5.0
1. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Extremely experience team members and supportive corporate structure enables the field teams to execute on national strategy

Kontras

The bonus structure can be a bit political

3.0
7. Mai 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Genentech's origin story and mission are genuinely inspiring — few companies can point to such a meaningful historical arc in medicine. Patient engagement is taken seriously and feels authentic, not performative. The campus is beautiful and the culture has real warmth.

Kontras

DDA is operating with significant gaps. First, the foundational data infrastructure is not mature enough to support the ambitions being set for the team. Second, the measurement culture has gotten ahead of the methodology, and no one in a position of authority seems to be asking hard questions about whether the numbers actually mean what they're being presented as meaning. Third, some management feel disconnected from the work itself, lacking the knowledge, hands-on experience, or relevant credentials. Individually any one of these would be manageable. Together these create an environment where it's hard to do rigorous work, rather work is performative, and be recognized for it.

2
Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle